A Phase 1 Study of LNCB74 in Advanced Solid Tumors — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(14 sites)
United States
Hoag Family Cancer Institute, Newport Beach, California St. Elizabeth Healthcare, Edgewood, Kentucky Dana Farber Cancer Institute, Boston, Massachusetts Washington University, Siteman Cancer Center, St Louis, Missouri John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack, New Jersey Last updated December 2025